Preventing Tumor Growth After Radiotherapy with SFK Inhibitors
Author Information
Author(s): Choi Yong June, Kim Myung Jun, Lee Young Joo, Choi Munkyung, Shim Wan Seob, Park Miso, Kim Yong-Chul, Kang Keon Wook
Primary Institution: Seoul National University
Hypothesis
Can targeting SRC family kinases (SFKs) prevent the formation of a pro-tumorigenic microenvironment induced by radiotherapy?
Conclusion
Targeting SFKs can reshape the tissue microenvironment and potentially prevent metastasis and recurrence after radiotherapy.
Supporting Evidence
- Radiotherapy can create a pro-tumorigenic microenvironment by causing tissue damage.
- SFK inhibitors can reverse myofibroblast activation and reduce fibrosis.
- Combining radiotherapy with SFK inhibitors improves survival in tumor-bearing mice.
Takeaway
Radiation can hurt healthy tissue and help tumors grow, but using certain drugs can stop this from happening.
Methodology
The study used mouse models to investigate the effects of SFK inhibitors on radiotherapy-induced lung fibrosis and tumor growth.
Limitations
The study primarily focused on early-stage lung fibrosis and may not apply to late-stage conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website